Company: SMNR
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001013762-25-003461
Chunk: 59

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 59
---
 vote on the appointment of directors. These provisions of our amended and restated memorandum and articles of association 35 may only be amended if approved by holders of at least 90% of the issued and outstanding ordinary shares (which shall include a simple majority of the holders of our Class B ordinary shares) entitled to vote thereon. Each of our directors hold office for a two -yearterm. Subject to any other special rights applicable to the shareholders, any vacancies on our board of directors may be filled by the affirmative vote of a majority of the remaining directors of our board of directors or by a majority of the holders of our ordinary shares (or, prior to an initial business combination, a majority of the holders of our Class B ordinary shares). Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Committees of the Board of Directors Our board of directors has one standing committee: an audit committee. Subject to phase -inrules and a limited exception, the rules of Nasdaq and Rule 10A -3of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Audit Committee Huifeng Chang, Jim Mao and Kevin D. Vassily serve as members of our audit committee. Our board of directors has determined that each of Huifeng Chang, Jim Mao and Kevin D. Vassily are independent under the Nasdaq listing standards and applicable SEC rules. Kevin Vassily serves as the Chair of the audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of whom must be independent within one year of the listing of the Class A Ordinary Shares. Each member of the audit committee is financially literate and our board of directors has determined that Kevin Vassily qualifies as an “audit committeefinancial expert” as defined in applicable SEC rules. The audit committee is responsible for: •meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; •monitoring the independence of the independent registered public accounting firm; •verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; •inquiring